Redwood City, California, United States · Hybrid
$211k–$264k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Healthcare Analytics, Oncology Analytics, Patient Journey Analysis, Market Opportunity Assessment, Claims Data Analysis
United States · Remote OK
$245k–$290k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Sales Leadership, Oncology Sales, Product Launch, Strategic Account Planning, Team Development
United States · Remote OK
$245k–$290k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Sales Leadership, Oncology Sales, Product Launch, Strategic Account Planning, Team Development
United States · Remote OK
$245k–$290k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Sales Leadership, Oncology Sales, Product Launch, Strategic Account Planning, Team Development
United States · Remote OK
$245k–$290k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Sales Leadership, Oncology Sales, Product Launch, Strategic Account Planning, Team Development
United States · Hybrid
$211k–$264k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Strategic Planning, Medical Affairs Operations, Project Management, Cross-functional Leadership, Launch Readiness
United States · Remote OK
$259k–$285k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Health Economics, Outcomes Research, Real World Evidence, Payer Strategy, Oncology
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Health Economics, Outcomes Research, Real World Evidence, Patient Reported Outcomes, Oncology HEOR
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Regulatory affairs, Oncology drug development, Regulatory strategy, Clinical development, Immuno-oncology
Redwood City, California, United States · Hybrid
$186k–$233k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Quality Assurance, Quality Systems, Regulatory Inspection Readiness, GxP Regulations, CAPA Governance
United States · Remote OK
$252k–$315k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Precision Medicine Strategy, Companion Diagnostics, Oncology Commercialization, Biomarker Strategy, Global Launch Planning
Italy · Hybrid
$144k–$179k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Regulatory affairs, Oncology, Strategic planning, Clinical development, Regulatory compliance
Redwood City, California, United States · Hybrid
$265k–$331k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical development, Oncology, Drug development, Regulatory affairs, Clinical trial design
Redwood City, California, United States · Hybrid
$265k–$331k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: GxP Compliance, Quality Management Systems, Regulatory Inspection Readiness, Risk Management, Strategic Leadership
United States · Hybrid
$106k–$132k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Executive support, Operations management, Calendar management, Project management, Vendor management
London, England, United Kingdom · Hybrid
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Regulatory Operations, Regulatory Affairs, eCTD, Veeva Vault RIM, DocuBridge
Redwood City, California, United States · Hybrid
$244k–$305k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Clinical data management, Oncology, Leadership, EDC systems, Medidata Rave
Redwood City, California, United States · Hybrid
$120k–$150k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Pharmacovigilance, Safety surveillance, Clinical trial protocols, Medical review, Signal detection
Redwood City, California, United States · Hybrid
$164k–$205k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Serialization, Traceability, Supply chain operations, DSCSA, EU FMD
Vienna, Austria · Remote OK
$116k–$145k/yr
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress dive…
Skills: Oncology, Account Management, Strategic Planning, Business Acumen, Market Access
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
Lead the analytics strategy for the lung cancer portfolio to generate actionable insights for portfolio strategy and launch readiness. Partner with cross-functional teams to analyze patient, physician, and market-level data to inform commercial decision-making.
Requires a bachelor's degree and 8+ years of experience in pharmaceutical or healthcare analytics, specifically within oncology. Must have demonstrated expertise with healthcare claims, EMR, and specialty pharmacy datasets.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.
Reporting to the Executive Director, Lung Analytics & Insights, the Director, Lung Analytics will serve as the analytics lead for Revolution Medicines’ lung cancer portfolio.
This role will partner closely with Commercial, Medical Affairs, Market Access, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance.
The role requires a strong understanding of the lung cancer treatment landscape, patient journey, biomarker-driven markets, and oncology data assets.
This position is based at our Redwood City, CA headquarters, with flexibility for remote candidates willing to travel regularly to the office.
Responsibilities include:
Lead analytics strategy and execution for Revolution Medicines’ lung cancer portfolio.
Partner with cross-functional stakeholders to identify key business questions and translate them into analytical plans and actionable recommendations.
Generate insights from patient-, physician-, claims-, EMR-, and market-level data to inform portfolio strategy, launch planning, and commercial decision-making.
Develop analyses to understand patient identification, biomarker testing patterns, treatment sequencing, referral pathways, and barriers to adoption.
Conduct market opportunity assessments, patient journey analyses, and competitive landscape evaluations to support strategic planning.
Design and execute segmentation, targeting, and opportunity identification analyses to inform customer engagement strategies.
Monitor evolving standards of care, treatment dynamics, and competitor activity across lung cancer indications.
Partner with Forecasting, Market Research, and Competitive Intelligence colleagues to develop an integrated view of market performance and future growth opportunities.
Lead development of key performance metrics, dashboards, and launch readiness assessments.
Inform data acquisition and data strategy decisions to ensure availability of fit-for-purpose oncology data assets.
Manage external analytics vendors and ensure timely delivery of high-quality analyses.
Communicate insights and strategic implications to senior leadership through clear, concise, and compelling recommendations.
Represent Revolution Medicines’ values in all internal and external interactions.
Bachelor’s degree required; advanced degree preferred.
8+ years of experience in pharmaceutical, biotechnology, healthcare analytics, or management consulting.
Oncology analytics experience required; lung cancer experience strongly preferred.
Demonstrated expertise working with healthcare claims, EMR, specialty pharmacy, and other patient-level datasets.
Experience supporting oncology product launches and pre-launch planning.
Strong analytical, problem-solving, and strategic thinking skills.
Proven ability to influence cross-functional teams and senior leadership.
Excellent communication and presentation skills.
Ability to thrive in a fast-paced, entrepreneurial environment.
MBA, MPH, MS, or PhD.
Deep understanding of NSCLC and biomarker-driven oncology markets.
Experience supporting targeted oncology therapies.
Experience with advanced analytics, predictive modeling, AI/ML applications, or commercial forecasting.
Prior experience in a growth-stage biotechnology company.
#LI-SS2 #LI-Hybrid
The base pay salary range for this full-time position for candidates working onsite at our headquarters in Redwood City, CA is listed below. The range displayed on each job posting is intended to be the base pay salary range for an individual working onsite in Redwood City and will be adjusted for the local market a candidate is based in. Our base pay salary ranges are determined by role, level, and location. Individual base pay salary is determined by multiple factors, including job-related skills, experience, market dynamics, and relevant education or training.
Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Revolution Medicines is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital status, medical condition, and veteran status.
Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect, process and use any personal data that you provide to us in accordance with our CCPA Notice and Privacy Policy. For additional information, please contact [email protected].
We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, or text message.
Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information, purchase equipment, or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @revmed.com email address.
If you believe you’ve been contacted by someone impersonating a Revolution Medicines recruiter, please report it to [email protected] so we can share these impersonations with our IT team for tracking and awareness.
Revolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution MedicineRevolution Medicine enables physicians to integrate personalized medicine into their practices in order to more effectively treat patients. Our genes play an important role in determining how we respond to about 75% of prescription drugs. Scientific research has demonstrated which genes predict these responses. According to the American Medical Association (AMA), 98% of physicians agree that knowing a patient’s genetic profile would help in prescribing medications. Yet, 90% of physicians do not feel they are adequately informed about how to apply genetic testing to treatment decisions. Our mission is to improve the quality of patient care by helping doctors determine optimal treatment strategies and more accurately predict treatment responses. Revolution Medicine has developed ScriptMatch, an analytical process that enables physicians to easily incorporate genetic testing into their practices. Our company solves a major issue in the clinical market and addresses an emerging trend in patient-driven healthcare: having clinical results that become part of the medical record and applicable to future treatments.
View all jobs at Revolution Medicine